Budget Impact Analysis of An Etanercept Biosimilar for The Treatment of All Licensed Etanercept Indications for Adults In Europe
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.2278
https://www.valueinhealthjournal.com/article/S1098-3015(15)04354-5/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
1688
First Page :
A639
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04354-5&doi=10.1016/j.jval.2015.09.2278